company background image
CDY

CellmidASX:CDY Stock Report

Market Cap

AU$11.4m

7D

-1.6%

1Y

-41.9%

Updated

18 Oct, 2021

Data

Company Financials +
CDY fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

CDY Overview

Cellmid Limited, a consumer health company, develops, manufactures, and markets anti-aging products for hair, skin, and wellbeing in Australia, the United States, China, and Japan.

Price History & Performance

Summary of all time highs, changes and price drops for Cellmid
Historical stock prices
Current Share PriceAU$0.061
52 Week HighAU$0.049
52 Week LowAU$0.14
Beta-1.47
1 Month Change15.09%
3 Month Change1.67%
1 Year Change-41.90%
3 Year Change-83.29%
5 Year Change-91.29%
Change since IPO-98.44%

Recent News & Updates

Shareholder Returns

CDYAU Personal ProductsAU Market
7D-1.6%2.4%0.9%
1Y-41.9%17.0%20.2%

Return vs Industry: CDY underperformed the Australian Personal Products industry which returned 17% over the past year.

Return vs Market: CDY underperformed the Australian Market which returned 20.2% over the past year.

Price Volatility

Is CDY's price volatile compared to industry and market?
CDY volatility
CDY Beta-1.47
Industry Beta0.70
Market Beta1

Stable Share Price: CDY is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: CDY's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004n/aMaria Halaszhttps://cellmid.com.au

Cellmid Limited, a consumer health company, develops, manufactures, and markets anti-aging products for hair, skin, and wellbeing in Australia, the United States, China, and Japan. It develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. In addition, the company markets its products through retailers and wholesalers, as well as through a direct-to-consumer, e-commerce platform.

Cellmid Fundamentals Summary

How do Cellmid's earnings and revenue compare to its market cap?
CDY fundamental statistics
Market CapAU$11.43m
Earnings (TTM)-AU$3.80m
Revenue (TTM)AU$5.82m

2.0x

P/S Ratio

-3.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CDY income statement (TTM)
RevenueAU$5.82m
Cost of RevenueAU$2.11m
Gross ProfitAU$3.70m
ExpensesAU$7.51m
Earnings-AU$3.80m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.02
Gross Margin63.68%
Net Profit Margin-65.42%
Debt/Equity Ratio9.0%

How did CDY perform over the long term?

See historical performance and comparison

Valuation

Is Cellmid undervalued compared to its fair value and its price relative to the market?

1.1x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate CDY's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate CDY's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: CDY is unprofitable, so we can't compare its PE Ratio to the Global Personal Products industry average.

PE vs Market: CDY is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CDY's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CDY is good value based on its PB Ratio (1.1x) compared to the AU Personal Products industry average (2.9x).


Future Growth

How is Cellmid forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

29.9%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if CDY's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if CDY's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CDY's revenue (29.9% per year) is forecast to grow faster than the Australian market (5.5% per year).

High Growth Revenue: CDY's revenue (29.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CDY's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Cellmid performed over the past 5 years?

-5.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CDY is currently unprofitable.

Growing Profit Margin: CDY is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CDY is unprofitable, and losses have increased over the past 5 years at a rate of 5.9% per year.

Accelerating Growth: Unable to compare CDY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CDY is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (23%).


Return on Equity

High ROE: CDY has a negative Return on Equity (-36.47%), as it is currently unprofitable.


Financial Health

How is Cellmid's financial position?


Financial Position Analysis

Short Term Liabilities: CDY's short term assets (A$11.3M) exceed its short term liabilities (A$1.9M).

Long Term Liabilities: CDY's short term assets (A$11.3M) exceed its long term liabilities (A$943.5K).


Debt to Equity History and Analysis

Debt Level: CDY's debt to equity ratio (9%) is considered satisfactory.

Reducing Debt: CDY's debt to equity ratio has reduced from 21.2% to 9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CDY has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: CDY has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 6.9% each year.


Dividend

What is Cellmid current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CDY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CDY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CDY's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CDY's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CDY's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Maria Halasz

14.5yrs

Tenure

AU$579,208

Compensation

Ms. Maria Halasz, MBA, BSc, has been the Chief Executive Officer of Cellmid Limited since April 14, 2007 and has been its Managing Director since November 2007. Ms. Halasz served as Managing Director of Ce...


CEO Compensation Analysis

Compensation vs Market: Maria's total compensation ($USD429.90K) is above average for companies of similar size in the Australian market ($USD302.72K).

Compensation vs Earnings: Maria's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CDY's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

Experienced Board: CDY's board of directors are considered experienced (3.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CDY insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.6%.


Top Shareholders

Company Information

Cellmid Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Cellmid Limited
  • Ticker: CDY
  • Exchange: ASX
  • Founded: 2004
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: AU$11.433m
  • Shares outstanding: 187.43m
  • Website: https://cellmid.com.au

Location

  • Cellmid Limited
  • 55 Clarence Street
  • Suite 204
  • Sydney
  • New South Wales
  • 2000
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/18 07:02
End of Day Share Price2021/10/15 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.